Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Testing effectiveness (Phase 2)UnknownNCT04720768
What this trial is testing

Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE

Who this might be right for
MelanomaMetastasis
Peter MacCallum Cancer Centre, Australia 78
Large-scale testing (Phase 3)WithdrawnNCT00226668
What this trial is testing

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Who this might be right for
Brain EdemaBrain Tumor
Celtic Pharma Development Services 120
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Early research (Phase 1)Ended earlyNCT01795313
What this trial is testing

Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

Who this might be right for
Ependymoma
James Felker 23
Not applicableWithdrawnNCT03804255
What this trial is testing

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Who this might be right for
Breast CarcinomaColorectal CarcinomaCommunity Practice+3 more
ECOG-ACRIN Cancer Research Group
Early research (Phase 1)Study completedNCT00313508
What this trial is testing

Dendritic Cell Vaccination During Lymphoid Reconstruction

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT02728349
What this trial is testing

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Who this might be right for
Glioblastoma
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd 26
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Large-scale testing (Phase 3)Looking for participantsNCT06071897
What this trial is testing

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Large-scale testing (Phase 3)UnknownNCT05783882
What this trial is testing

Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Biocad 114
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Large-scale testing (Phase 3)Looking for participantsNCT05382338
What this trial is testing

Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Who this might be right for
Childhood Medulloblastoma
Children's Oncology Group 225
Testing effectiveness (Phase 2)Ended earlyNCT03259425
What this trial is testing

Neoadjuvant Trial of Nivolumab in Combination With HF10 Oncolytic Viral Therapy in Resectable Stage IIIB, IIIC, IVM1a Melanoma

Who this might be right for
Melanoma
University of Utah 7
Not applicableLooking for participantsNCT07236840
What this trial is testing

Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

Who this might be right for
CNS TumorArtificial Intelligence (AI)Glioma+1 more
Tata Memorial Centre 600
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Testing effectiveness (Phase 2)Study completedNCT02698410
What this trial is testing

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.

Who this might be right for
Neuroendocrine Tumours
Ipsen 40
Testing effectiveness (Phase 2)Ended earlyNCT04924413
What this trial is testing

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Quanli Gao 9
Early research (Phase 1)Study completedNCT00185848
What this trial is testing

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Who this might be right for
Brain CancerArthritis, RheumatoidCentral Nervous System Neoplasms+1 more
Sanjiv Sam Gambhir 10
Next Page